Ipamorelin Peptide UK: Research, Mechanism and Study Data
Ipamorelin releases growth hormone without the cortisol and prolactin that its predecessors carried. Five residues, selective binding, and why that selectivity matters.
GHRP-6 Peptide UK: Research, Mechanism and Study Data
GHRP-6 was one of the first growth hormone secretagogues ever synthesised, and much of what came after is a refinement of it. Six residues, and the research that followed.
SS-31 Peptide UK Guide: Research, Mechanism and Study Data
SS-31 targets cardiolipin, a lipid found nowhere in the cell except the inner mitochondrial membrane. Four residues, one address, and a decade of mitochondrial research.
Sermorelin Peptide UK Guide: Research, Mechanism and Study Data
Sermorelin is GRF (1-29) – the shortest piece of GHRH that still works. Why twenty-nine residues is the cut-off, and what the research on it shows.
Bacteriostatic Water UK Guide
Bacteriostatic water is sterile water plus 0.9% benzyl alcohol, and that small difference is what lets a reconstituted vial last weeks instead of hours.
BPC-157 Peptide UK Guide: Tissue Research, Mechanism and Study Data
A 15-residue peptide isolated from human gastric juice, stable in stomach acid, and studied across tissue repair, angiogenesis and gut models. What the evidence actually shows.
Thymosin Alpha-1: Approved in 35 Countries, Not in the US
Forty years of trials, more than 11,000 patients, and prescription approval in over 35 countries — yet never approved in the United States. That gap is the most interesting thing about this peptide.
KPV Peptide UK: Research, Mechanism and Study Data
Three amino acids is all KPV is, and it is the business end of alpha-MSH. Lys-Pro-Val, the inflammatory pathway it acts on, and what the intestinal research found.
TB-500 (Thymosin Beta-4) UK Guide
TB-500 is supplied as full-length thymosin beta-4, not the short fragment many suppliers ship under the same name. Forty-three residues, actin binding, and why that matters.
Retatrutide UK Guide: Research, Mechanism and Study Data
Retatrutide hits three receptors where tirzepatide hits two and semaglutide one. What that third target adds, what the phase 2 data reported, and where the research goes next.
